ARCHIVES

EntreMed Issued U.S. Patent For Active Parts Of Endostatin.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

Increase Cancer Center Grants More Than R01s, SPOREs, Report Tells NCI

February 28, 2003

In Brief: Hammond Resigned As ACS Officer; Wykoff Slated To Direct FDA Special Populations Office

November 20, 1992

Roswell Park’s Future “Bright” As Center Snares Leading Scientists, Hohn Says.

January 18, 2002

DCPC Advisors Approve Five New RFA concepts, Set Aside $33.6 Million

June 4, 1993

In Brief: NCAB ask Force Supports Group-Led Data and Safety Monitoring Committees

August 19, 1994

NCCN, ACS Offer Publication For Patients About Nausea.

June 22, 2001